Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,251
datasets available to search
ShareScore release 0.9.0
Dataset results
3,251 results for “ovarian cancer”
A Study LY2228820 for Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01663857. IPD Sharing: YES. Countries: 4. Publications: 1.
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
ClinicalTrials.gov study NCT00003644. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
ClinicalTrials.gov study NCT01468909. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
ClinicalTrials.gov study NCT02354586. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received a
ClinicalTrials.gov study NCT02282020. IPD Sharing: YES. Countries: 13. Publications: 4.
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
ClinicalTrials.gov study NCT03737643. IPD Sharing: YES. Countries: 20. Publications: 1.
Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
ClinicalTrials.gov study NCT02718417. IPD Sharing: YES. Countries: 25. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer
ClinicalTrials.gov study NCT03574779. IPD Sharing: NO. Countries: 3. Publications: 2.
Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
ClinicalTrials.gov study NCT00753545. IPD Sharing: YES. Countries: 17. Publications: 8.
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT02101775. IPD Sharing: Not stated. Countries: 3. Publications: 1.
p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246
ClinicalTrials.gov study NCT02098343. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
ClinicalTrials.gov study NCT00617188. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00182767. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00494442. IPD Sharing: Not stated. Countries: 5. Publications: 3.
A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
ClinicalTrials.gov study NCT01239732. IPD Sharing: Not stated. Countries: 37. Publications: 1.
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT00316173. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status
ClinicalTrials.gov study NCT02983799. IPD Sharing: YES. Countries: 2. Publications: 1.
Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT01196741. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
ClinicalTrials.gov study NCT02903771. IPD Sharing: NO. Countries: 2. Publications: 1.
Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT02272790. IPD Sharing: YES. Countries: 3. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.